Literature DB >> 8812448

Cloning of the VASP (vasodilator-stimulated phosphoprotein) genes in human and mouse: structure, sequence, and chromosomal localization.

M Zimmer1, T Fink, L Fischer, W Hauser, K Scherer, P Lichter, U Walter.   

Abstract

The genes encoding the vasodilator-stimulated phosphoprotein (VASP) in human and mouse were isolated, and major parts were sequenced. In both species the gene is composed of 13 exons with conserved exon-intron positions. The mouse VASP cDNA sequence was deduced from the genomic sequence. The predicted amino acid sequence is 89% identical to the human protein. The high nucleotide sequence homology extends not only over the coding regions but also into the 3'-UTRs, indicating a possible function in mRNA targeting or regulation of translation. Prominent 5' CpG islands including multiple SP1 sites indicate a housekeeping function of VASP. Using cosmid DNA as a probe for fluorescence in situ hybridization, the human VASP gene was assigned to chromosome 19q13.2-q13.3, an extended region with homology to mouse chromosome 7. A sequence overlap of the VASP 5'-region with the telomeric end of a cosmid contig physically links the VASP gene with ERCC1. VASP is located about 92 kb distal to ERCC1 and about 300 kb proximal to the myotonic dystrophy protein kinase gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8812448     DOI: 10.1006/geno.1996.0457

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  4 in total

1.  Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity.

Authors:  L J Ball; R Kühne; B Hoffmann; A Häfner; P Schmieder; R Volkmer-Engert; M Hof; M Wahl; J Schneider-Mergener; U Walter; H Oschkinat; T Jarchau
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

2.  Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice.

Authors:  W Hauser; K P Knobeloch; M Eigenthaler; S Gambaryan; V Krenn; J Geiger; M Glazova; E Rohde; I Horak; U Walter; M Zimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein.

Authors:  K Liu; L Li; P E Nisson; C Gruber; J Jessee; S N Cohen
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.

Authors:  A Aszódi; A Pfeifer; M Ahmad; M Glauner; X H Zhou; L Ny; K E Andersson; B Kehrel; S Offermanns; R Fässler
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.